12:00 AM
 | 
Jul 27, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aliskiren/valsartan combination regulatory update

Novartis said that in June it submitted an application in Europe for a single pill combination of its Tekturna/...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >